CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,042,865 | -8.1% | 108,100 | +13.4% | 0.01% | -12.5% |
| Q2 2023 | $5,488,327 | +20.7% | 95,300 | -5.8% | 0.01% | +14.3% |
| Q1 2023 | $4,547,928 | +12.3% | 101,200 | -0.8% | 0.01% | +16.7% |
| Q4 2022 | $4,049,400 | -30.0% | 102,000 | +16.0% | 0.01% | -33.3% |
| Q3 2022 | $5,786,000 | +7.3% | 87,900 | -0.9% | 0.01% | +12.5% |
| Q2 2022 | $5,392,000 | -13.9% | 88,700 | -8.6% | 0.01% | 0.0% |
| Q1 2022 | $6,266,000 | -17.0% | 97,000 | +3.1% | 0.01% | -11.1% |
| Q4 2021 | $7,549,000 | -11.2% | 94,100 | +24.5% | 0.01% | -18.2% |
| Q3 2021 | $8,497,000 | – | 75,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |